Clinical trials
Phase 3 Hyperparathyroidism, Secondary trials in the United States
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2010 | 2 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 5 |
| 2014 | 2 |
| 2015 | 1 |
| 2019 | 1 |
| 2020 | 1 |
| 2023 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 12 |
| Terminated | 5 |
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Amgen | 10 |
| OPKO IP Holdings II, Inc. | 2 |
| Pathalys Pharma | 2 |
| AbbVie | 1 |
| Kenneth R. Phelps, M.D. | 1 |
| OPKO Health, Inc. | 1 |
| Thomas Jefferson University | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hyperparathyroidism, Secondary | 18 |
| Renal Insufficiency, Chronic | 14 |
| Hyperparathyroidism | 5 |
| Hypocalcemia | 4 |
| Kidney Failure, Chronic | 4 |
| Vitamin D Deficiency | 4 |
| Kidney Diseases | 3 |
| Parathyroid Diseases | 2 |
| Renal Insufficiency | 2 |
| Coronary Artery Disease | 1 |
Trials
Showing 1 to 18 of 18. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.